Fluticasone and Salmeterol Oral Inhalation Uses, Dosage, Side Effects and Interactions
Advair Diskus
Advair Diskus is a brand of fluticasone and salmeterol oral inhalation that comes as an inhalation powder. An FDA-approved generic with the same active ingredients is listed.
Advair HFA
Advair HFA was approved by the FDA in June 2006 as an inhaler. The FDA rates no generic as a substitute for it.
AirDuo RespiClick
AirDuo RespiClick was approved by the FDA in January 2017 as an inhalation powder. The FDA rates no generic as a substitute for it.
Wixela Inhub
Wixela Inhub is a generic fluticasone and salmeterol oral inhalation sold under its own name, approved by the FDA in January 2019. An FDA-approved generic with the same active ingredients is listed.
Fluticasone and salmeterol is an inhaled combination of a corticosteroid and a long-acting bronchodilator, used twice daily to treat asthma and, in the powder form, to manage COPD.
Quick links
Ask Anything About Fluticasone and Salmeterol Oral InhalationType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Fluticasone and Salmeterol Oral Inhalation in Short
- Drug classes Corticosteroid; beta2-Adrenergic Agonist How the FDA classifies it
What it treatsThis combination is used for asthma in people aged 4 years and older. It is meant for people whose asthma is not controlled on a long-term controller medicine like an inhaled corticosteroid, or whose asthma needs both types of medicine from the start.
- How you get it Prescription only
- Comes asInhalation powder and inhalerAvailable strengths (fluticasone/salmeterol oral inhalation)
Inhalation powder (inhaled)
- 55 mcg/14 mcg
- 100 mcg/50 mcg
- 113 mcg/14 mcg
- 232 mcg/14 mcg
- 250 mcg/50 mcg
- 500 mcg/50 mcg
See forms and strengths+ 3 more strengthsShow fewer strengths
Inhaler (inhaled)
- 45 mcg/21 mcg
- 115 mcg/21 mcg
- 230 mcg/21 mcg
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What pharmacies pay
- Generic$1.01 to $114.34 each (inhalation powder)
- Advair Diskus (brand)$2.49 to $4.23 each (inhalation powder)
- Most generic inhalation powder strengths about $1.60
The pharmacy’s own cost, national average. Not your price See every price+ 2 more price detailsShow fewer price details
- Inhalers, generic: $16.54 to $27.35 per gram of the inhaler’s contents
- Inhalers, Advair HFA: $18.78 to $35.00 per gram of the inhaler’s contents
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Fluticasone and salmeterol (Advair, Wixela Inhub) is a controller inhaler for asthma and, in the powder form, COPD, pairing a steroid that calms airway inflammation with a long-acting bronchodilator (LABA) that keeps airways open; on the market since about 2001, with generics approved, it is one of the most familiar step-ups from an inhaled steroid alone. Most people tolerate it well; hoarseness, sore throat and thrush (a mouth yeast infection) are the usual complaints, and rinsing and spitting after each dose helps. It is not a rescue inhaler, so keep a short-acting one for sudden symptoms, and never pair it with another LABA, which risks a serious overdose.
Key Takeaways From the HelloPharmacist Team
- Use it twice a day, about 12 hours apart, every day even when breathing feels fine, and never take extra puffs.
- Call your prescriber if you reach for your rescue inhaler more often, since that signals your asthma or COPD is getting worse.
- With COPD, call about any flare-up that feels different or comes with fever, since pneumonia is a known risk and can look similar.
- Generics such as Wixela Inhub are FDA-approved, so ask which your plan covers and have someone check your technique on that device.
Patient Information Guide for Fluticasone and Salmeterol Oral Inhalation
What It’s Used For
This combination of a corticosteroid and a long-acting bronchodilator is used for:
- Asthma: twice-daily treatment in people aged 4 years and older who need an inhaled steroid plus a LABA.
- COPD (inhalation powder, 250/50 strength only): maintenance treatment of airflow obstruction, including chronic bronchitis and emphysema, and reducing flare-ups in people with a history of them.
- Not for relief of sudden bronchospasm.
How It Works
Fluticasone is a corticosteroid that reduces airway inflammation, a key part of asthma. Salmeterol is a long-acting beta agonist that relaxes the muscles around the airways and also blocks release of inflammatory substances from mast cells. Together they help keep airways open and calmer.
Drug Class
Drug Class
- beta2-Adrenergic Agonist from salmeterol
- Corticosteroid from fluticasone
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Fluticasone and Salmeterol Oral Inhalation has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- beta2-Adrenergic Agonist from salmeterol
- Corticosteroid from fluticasone
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Adrenergic beta2-Agonists from salmeterol
- Corticosteroid Hormone Receptor Agonists from fluticasone
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Fluticasone and Salmeterol Oral Inhalation in the FDA’s index.
From our Patient Information GuideFluticasone is a corticosteroid that reduces airway inflammation, a key part of asthma. Salmeterol is a long-acting beta agonist that relaxes the muscles around the airways and also blocks release of inflammatory substances from mast cells. Read How Fluticasone and Salmeterol Oral Inhalation Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Fluticasone and Salmeterol Oral Inhalation in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
The inhalation powder is taken by mouth inhalation only, one inhalation twice daily, about 12 hours apart.
- Rinse your mouth with water afterward and spit it out.
- Do not take more than one inhalation twice daily.
- Use a short-acting rescue inhaler for symptoms between doses.
- If you used a short-acting beta agonist on a regular schedule, ask your prescriber about stopping that routine.
Follow your prescriber's directions and the product label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Fluticasone and Salmeterol Oral Inhalation Inhalation Powder
Asthma
Adults and children 12 years and older Starting dose 1 inhalation twice a day Highest dose 1 inhalation of 500/50 mcg twice a day
- 1 inhalation twice daily, approximately 12 hours apart, of Fluticasone Propionate/Salmeterol DISKUS inhalation powder 100/50 mcg, 250/50 mcg or 500/50 mcg
- Starting dosage is based on asthma severity
Children 4 to 11 years old Usual dose 1 inhalation of 100/50 mcg twice a day
- 1 inhalation of Fluticasone Propionate/Salmeterol DISKUS inhalation powder 100/50 mcg twice daily, approximately 12 hours apart
Good to know
For patients not controlled on an ICS
COPD (long-term lung disease)
For adults
Usual dose 1 inhalation of 250/50 mcg twice a day
- 1 inhalation of Fluticasone Propionate/Salmeterol DISKUS inhalation powder 250/50 mcg twice daily, approximately 12 hours apart
COPD stands for chronic obstructive pulmonary disease.
AirDuo RespiClick
Asthma
People with more severe asthma Starting dose 1 inhalation of 113 mcg/14 mcg twice a day Highest dose 1 inhalation of 232 mcg/14 mcg twice a day
- Or 1 inhalation of 232 mcg/14 mcg twice daily
People switching from another inhaled steroid or combination inhaler Highest dose 1 inhalation of 232 mcg/14 mcg twice a day
- 1 inhalation of low (55 mcg/14 mcg), medium (113 mcg/14 mcg) or high (232 mcg/14 mcg) twice daily by oral inhalation, based on the strength of the previous inhaled corticosteroid and disease severity
Fluticasone Propionate and Salmeterol HFA
Asthma
For adults and children 12 years and older
Starting dose 2 inhalations twice a day
Highest dose 2 inhalations of 230 mcg/21 mcg twice a day
- 2 oral inhalations twice daily, approximately 12 hours apart, of Fluticasone Propionate and Salmeterol HFA 45 mcg/21 mcg, 115 mcg/21 mcg or 230 mcg/21 mcg
- Starting dosage is based on asthma severity
Side Effects
Common side effects include:
Common side effects
- Upper respiratory infections or inflammation
- Sore throat (pharyngitis)
- Hoarseness or voice changes (dysphonia)
- Yeast infection in the mouth (oral candidiasis)
- Cough or bronchitis
- Headache
- Nausea and vomiting
- Pneumonia in people with COPD
- Muscle or joint pain (COPD)
When to get medical help
- Get help right away if your breathing suddenly worsens right after a dose (paradoxical bronchospasm). Stop the medicine and call your doctor.
- Call your doctor if your asthma or COPD is getting worse or you need your rescue inhaler more often.
- Call your doctor if you have signs of pneumonia, especially with COPD, since symptoms can resemble a flare-up.
- Call your doctor about white patches or soreness in your mouth or throat, which can be a yeast infection.
- Seek care for a fast or pounding heartbeat, chest pain, tremor or severe nervousness.
- Tell your doctor about vision changes or eye symptoms, since glaucoma and cataracts can occur with long-term inhaled corticosteroids.
- Contact your doctor if you are exposed to chickenpox or measles, which can be more serious while using corticosteroids.
Seek help for sudden worsening breathing after a dose, signs of pneumonia, fast or irregular heartbeat, or vision changes.
Warnings and Precautions
- LABA risk: salmeterol alone for asthma raises the risk of asthma-related death. Combined with a steroid, this was not significantly increased in large trials.
- Not for emergencies: do not start it during a rapidly worsening attack.
- Overuse: too many doses or other LABAs can cause serious heart effects.
- Pneumonia in COPD and mouth yeast infections.
- Steroid effects: immune suppression, adrenal suppression, lower bone density, slowed growth in children, glaucoma and cataracts.
- Paradoxical bronchospasm: stop and seek help if breathing worsens right after a dose.
Interactions
Several medicines can change how this one works or add risk:
- Strong CYP3A4 inhibitors (ritonavir, ketoconazole): raise steroid and heart-related effects.
- Other LABAs: overdose risk.
- MAO inhibitors and tricyclic antidepressants: can strengthen salmeterol's effects on blood vessels.
- Beta-blockers: may block the benefit and cause bronchospasm.
- Non-potassium-sparing diuretics: may worsen low potassium or ECG changes.
Interactions Listed in the FDA-Approved Label
From the Fluticasone and Salmeterol Oral Inhalation prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Strong CYP3A4 inhibitors For example: ritonavir, ketoconazoleWhat happensMay increase systemic corticosteroid and cardiovascular effects.What to doUse not recommended.
-
Monoamine oxidase inhibitors and tricyclic antidepressantsWhat happensMay potentiate the effect of salmeterol on the vascular system.What to doUse with extreme caution, including within 2 weeks of stopping these agents.
-
Beta-blockersWhat happensMay block the bronchodilatory effects of beta-agonists and produce severe bronchospasm.What to doUse with caution; patients with asthma or COPD should not normally be treated with beta-blockers; cardioselective ones could be considered.
-
Non-potassium-sparing diuretics (loop or thiazide)What happensECG changes and/or hypokalemia may be acutely worsened by beta-agonists.What to doUse with caution.
-
Short-acting beta2-agonists, methylxanthines, intranasal corticosteroidsWhat happensUsed together commonly in asthma or COPD without adverse drug reactions.
Read the label’s full interactions text
7 DRUG INTERACTIONS Fluticasone propionate and salmeterol inhalation powder has been used concomitantly with other drugs, including short-acting beta 2 -agonists, methylxanthines, and intranasal corticosteroids, commonly used in patients with asthma or COPD without adverse drug reactions. No formal drug interaction trials have been performed with fluticasone propionate and salmeterol inhalation powder. • Strong cytochrome P450 3A4 inhibitors (e.g., ritonavir, ketoconazole): Use not recommended. May increase risk of systemic corticosteroid and cardiovascular effects. • Monoamine oxidase inhibitors and tricyclic antidepressants: Use with extreme caution. May potentiate effect of salmeterol on vascular system. • Beta-blockers: Use with caution. May block bronchodilatory effects of beta-agonists and produce severe bronchospasm. • Diuretics: Use with caution. Electrocardiographic changes and/or hypokalemia associated with non–potassium-sparing diuretics may worsen with concomitant beta-agonists. 7.1 Inhibitors of Cytochrome P450 3A4 Fluticasone propionate and salmeterol, the individual components of Wixela Inhub ®, are substrates of CYP3A4. The use of strong CYP3A4 inhibitors (e.g., ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, ketoconazole, telithromycin) with Wixela Inhub ® is not recommended because increased systemic corticosteroid and increased cardiovascular adverse effects may occur. Ritonavir Fluticasone Propionate A drug interaction trial with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a strong CYP3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use for sudden asthma or COPD attacks.
- Avoid if you have a severe milk protein allergy or allergy to its ingredients.
- Use with caution with heart or nervous system disorders, seizures, thyroid overactivity, diabetes or ketoacidosis.
- Use with caution with active infections such as tuberculosis or eye herpes.
- Tell your doctor if pregnant or breastfeeding.
- Children need growth monitoring.
- Older adults with COPD had more pneumonia.
- Tell your doctor about liver problems.
Overdose
Too much can cause excess beta-stimulation: fast or irregular heartbeat, tremor, nervousness, headache, chest pain, muscle cramps, seizures, and QTc prolongation that can lead to dangerous heart rhythms. Long-term steroid excess can cause signs of hypercorticism. Treatment is to stop the medicine and give supportive care with cardiac monitoring.
How Your Body Processes It
Both drugs act locally in the lungs, so blood levels do not predict benefit. Fluticasone peaks in about 1 to 2 hours, and swallowed fluticasone is barely absorbed (under 1%). Salmeterol peaks in about 5 minutes, and blood levels are low or undetectable at recommended doses. Salmeterol is also processed by the CYP3A4 enzyme.
Storage
Store at room temperature between 68°F and 77°F (20°C and 25°C); excursions permitted from 59°F to 86°F (15°C to 30°C) . Store in a dry place away from direct heat or sunlight. Keep out of reach of children.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Fluticasone and Salmeterol Oral Inhalation: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Fluticasone and Salmeterol Oral Inhalation — the kind of thing our pharmacy team would talk through with you at the counter.
What is this inhaler for?
How do I use it?
What if I feel short of breath between doses?
What side effects should I expect?
Can I take it with my other medicines?
Is it safe in pregnancy?
Is fluticasone and salmeterol oral inhalation available over the counter?
When was fluticasone and salmeterol oral inhalation first available?
Who makes fluticasone and salmeterol oral inhalation?
What is the brand name of fluticasone and salmeterol oral inhalation?
What is the generic name of Advair Diskus?
What drug class is fluticasone and salmeterol oral inhalation?
Is there a generic version of fluticasone and salmeterol oral inhalation?
What strengths does fluticasone and salmeterol oral inhalation come in?
How much does fluticasone and salmeterol oral inhalation cost?
Where can I read the fluticasone and salmeterol oral inhalation prescribing information (package insert)?
Is fluticasone and salmeterol oral inhalation gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Fluticasone and Salmeterol Oral Inhalation
Skip the scrolling. Ask in your own words and get an answer from Fluticasone and Salmeterol Oral Inhalation’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Fluticasone and Salmeterol Oral Inhalation’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Fluticasone and Salmeterol Oral Inhalation on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Fluticasone and Salmeterol Oral Inhalation Forms and Strengths (How It Comes)
Fluticasone and Salmeterol Oral Inhalation comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Fluticasone and Salmeterol Oral Inhalation inactive ingredients by manufacturer.
Inhalation powder
How this form is used
- Wixela Inhub is used for twice-daily treatment of asthma in people aged 4 years and older.
- Wixela Inhub is used for maintenance treatment of COPD, including reducing exacerbations in people with a history of them.
- Wixela Inhub is for oral inhalation only, one inhalation twice daily about 12 hours apart.
- With Wixela Inhub, rinse your mouth with water after use and do not swallow the water.
- Wixela Inhub should not be used for sudden breathing symptoms.
Inhaler
Fluticasone and Salmeterol Oral Inhalation on the U.S. Market: Products, Makers and Brands
How Fluticasone and Salmeterol Oral Inhalation appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
14 companies list 60 Fluticasone and Salmeterol Oral Inhalation product records with the FDA, mostly as inhalation powder, inhaler; the earliest marketing or approval year on record is 2001. Brand names in the directory today include Advair Diskus, Advair HFA, AirDuo RespiClick and 1 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Fluticasone and Salmeterol Oral Inhalation Is Used (Medicaid Data)
How many Fluticasone and Salmeterol Oral Inhalation prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Fluticasone and Salmeterol Oral Inhalation prescribed? Of the 1,682 medications we measure, Fluticasone and Salmeterol Oral Inhalation ranks #122 by Medicaid prescriptions — more than 93% of them.
Utilization by Fluticasone and Salmeterol Oral Inhalation product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler Most dispensed
5 of 15 listed NDCs had Medicaid claims. RxNorm 896209
60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
5 of 15 listed NDCs had Medicaid claims. RxNorm 896184
60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
5 of 10 listed NDCs had Medicaid claims. RxNorm 896228
120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
2 of 4 listed NDCs had Medicaid claims. RxNorm 896244
120 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
2 of 2 listed NDCs had Medicaid claims. RxNorm 896272
120 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
2 of 2 listed NDCs had Medicaid claims. RxNorm 896236
60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler
2 of 5 listed NDCs had Medicaid claims. RxNorm 1918203
60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler
2 of 5 listed NDCs had Medicaid claims. RxNorm 1918194
60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler
2 of 5 listed NDCs had Medicaid claims. RxNorm 1918209
60 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
1 of 1 listed NDCs had Medicaid claims. RxNorm 896239
60 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
1 of 1 listed NDCs had Medicaid claims. RxNorm 896267
60 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
1 of 1 listed NDCs had Medicaid claims. RxNorm 896231
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 30 of the 66 listed Fluticasone and Salmeterol Oral Inhalation NDCs had Medicaid claims.
Compare Fluticasone and Salmeterol Oral Inhalation Products
A representative set of FDA-listed product records for Fluticasone and Salmeterol Oral Inhalation — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhalation powder | ||||
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Cipla USA Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Cipla USA Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Cipla USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Lannett Company, Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Lannett Company, Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Proficient Rx LP | NDA AUTHORIZED GENERIC | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Remedyrepack Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Remedyrepack Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Sportpharm LLC | NDA AUTHORIZED GENERIC | View label ↗ |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Sportpharm LLC | NDA AUTHORIZED GENERIC | View label ↗ |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Respiratory, LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Respiratory, LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Respiratory, LLC | NDA | View NDC → |
| 💊Inhaler | ||||
| FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| FLUTICASONE PROPIONATE 45 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 230 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 45 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 230 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
Showing 60 of 60 products — FDA National Drug Code Directory. See every product, package size and price: browse all 60 Fluticasone and Salmeterol Oral Inhalation NDCs →
Fluticasone and Salmeterol Oral Inhalation Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Fluticasone and Salmeterol Oral Inhalation — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Fluticasone and Salmeterol Oral Inhalation in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Fluticasone and Salmeterol Oral Inhalation FDA Approval History
How Fluticasone and Salmeterol Oral Inhalation went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Fluticasone and Salmeterol Oral Inhalation Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Fluticasone and Salmeterol recalls since July 2021.
✅No Fluticasone and Salmeterol recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Fluticasone and Salmeterol Oral Inhalation in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 2
- Strengths
- 18
- Forms in current FDA listings
- 2 of 2
RxCUI 284635 -
Dose form (SCDF) Dry Powder InhalerIn current FDA listings
RxCUI 746717Its 12 strengths (SCD)-
14 actuation fluticasone propionate 0.1 mg/actuation / salmeterol 0.05 mg/actuation
RxCUI 896161 -
14 actuation fluticasone propionate 0.25 mg/actuation / salmeterol 0.05 mg/actuation
RxCUI 896186 -
14 actuation fluticasone propionate 0.5 mg/actuation / salmeterol 0.05 mg/actuation
RxCUI 896218 -
Sensor 60 actuation fluticasone propionate 0.055 mg/actuation / salmeterol 0.014 mg/actuation
RxCUI 2395829 -
Sensor 60 actuation fluticasone propionate 0.113 mg/actuation / salmeterol 0.014 mg/actuation
RxCUI 2395826 -
Sensor 60 actuation fluticasone propionate 0.232 mg/actuation / salmeterol 0.014 mg/actuation
RxCUI 2395832 -
60 actuation fluticasone propionate 0.055 mg/actuation / salmeterol 0.014 mg/actuation
RxCUI 1918209 -
60 actuation fluticasone propionate 0.1 mg/actuation / salmeterol 0.05 mg/actuation
RxCUI 896184 -
60 actuation fluticasone propionate 0.113 mg/actuation / salmeterol 0.014 mg/actuation
RxCUI 1918194 -
60 actuation fluticasone propionate 0.232 mg/actuation / salmeterol 0.014 mg/actuation
RxCUI 1918203 -
60 actuation fluticasone propionate 0.25 mg/actuation / salmeterol 0.05 mg/actuation
RxCUI 896209 -
60 actuation fluticasone propionate 0.5 mg/actuation / salmeterol 0.05 mg/actuation
RxCUI 896228
-
14 actuation fluticasone propionate 0.1 mg/actuation / salmeterol 0.05 mg/actuation
-
Dose form (SCDF) Metered Dose InhalerIn current FDA listings
RxCUI 744485Its 6 strengths (SCD)-
60 actuation fluticasone propionate 0.045 mg/actuation / salmeterol 0.021 mg/actuation
RxCUI 896231 -
60 actuation fluticasone propionate 0.115 mg/actuation / salmeterol 0.021 mg/actuation
RxCUI 896239 -
60 actuation fluticasone propionate 0.23 mg/actuation / salmeterol 0.021 mg/actuation
RxCUI 896267 -
120 actuation fluticasone propionate 0.045 mg/actuation / salmeterol 0.021 mg/actuation
RxCUI 896236 -
120 actuation fluticasone propionate 0.115 mg/actuation / salmeterol 0.021 mg/actuation
RxCUI 896244 -
120 actuation fluticasone propionate 0.23 mg/actuation / salmeterol 0.021 mg/actuation
RxCUI 896272
-
60 actuation fluticasone propionate 0.045 mg/actuation / salmeterol 0.021 mg/actuation
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Fluticasone and Salmeterol Oral Inhalation Supply and Shortage Status
Whether Fluticasone and Salmeterol Oral Inhalation is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Fluticasone and Salmeterol Oral Inhalation Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Fluticasone and Salmeterol Oral Inhalation: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a form, the generic or the brand, and a strength to see how its price has changed since Nov 2023.
At this strength, Advair Diskus costs pharmacies $2.49 each.
For the generic SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg inhalation powder, pharmacies paid an average of $1.01 each as of Nov 18, 2026, down 12% from $1.15 a year earlier. At this strength, Advair Diskus costs pharmacies $2.49 each.
- What pharmacies pay now
- $1.01
- each, as of Nov 18, 2026
- Last 4 weeks
- Down 0.6%
- from $1.01 on Oct 21, 2026
- Last 12 months
- Down 12%
- from $1.15 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.802 to $1.32
- each
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $1.01 |
| Oct 2026 | $1.01 |
| Sep 2026 | $1.07 |
| Aug 2026 | $1.12 |
| Jul 2026 | $1.14 |
| Jun 2026 | $1.14 |
| May 2026 | $1.13 |
| Apr 2026 | $1.12 |
| Mar 2026 | $1.12 |
| Feb 2026 | $1.13 |
| Jan 2026 | $1.15 |
| Dec 2025 | $1.16 |
| Nov 2025 | $1.15 |
| Oct 2025 | $1.16 |
| Sep 2025 | $1.17 |
| Aug 2025 | $1.23 |
| Jul 2025 | $1.22 |
| Jun 2025 | $1.21 |
| May 2025 | $1.19 |
| Apr 2025 | $1.19 |
| Mar 2025 | $1.20 |
| Feb 2025 | $1.14 |
| Jan 2025 | $1.06 |
| Dec 2024 | $1.06 |
| Nov 2024 | $0.914 |
| Oct 2024 | $1.21 |
| Sep 2024 | $1.23 |
| Aug 2024 | $1.21 |
| Jul 2024 | $0.900 |
| Jun 2024 | $1.23 |
| May 2024 | $0.802 |
| Apr 2024 | $0.929 |
| Mar 2024 | $1.28 |
| Feb 2024 | $1.28 |
| Jan 2024 | $1.31 |
| Dec 2023 | $1.32 |
| Nov 2023 | $1.23 |
See all 18 prices in a table
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Inhalation powder · Respiratory (inhalation) | SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Generic | $1.01 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Advair Diskus (brand) | $2.49 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Generic | $1.20 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Advair Diskus (brand) | $3.12 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Generic | $1.60 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Advair Diskus (brand) | $4.23 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Generic | $114.34 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Generic | $1.01 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Generic | $105.06 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Generic | $104.36 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Generic | $1.20 each | NDC details & price history |
| Inhalation powder · Respiratory (inhalation) | FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Generic | $1.60 each | NDC details & price history |
| Inhaler · Respiratory (inhalation) | FLUTICASONE PROPIONATE 45 mcg/1; SALMETEROL XINAFOATE 21 mcg | Generic | $16.54 per gram | NDC details & price history |
| Inhaler · Respiratory (inhalation) | FLUTICASONE PROPIONATE 45 mcg/1; SALMETEROL XINAFOATE 21 mcg | Advair HFA (brand) | $19.97–$20.02 per gram | NDC details & price history |
| Inhaler · Respiratory (inhalation) | FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Generic | $20.67 per gram | NDC details & price history |
| Inhaler · Respiratory (inhalation) | FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Advair HFA (brand) | $18.78–$25.39 per gram | NDC details & price history |
| Inhaler · Respiratory (inhalation) | FLUTICASONE PROPIONATE 230 mcg/1; SALMETEROL XINAFOATE 21 mcg | Generic | $27.35 per gram | NDC details & price history |
| Inhaler · Respiratory (inhalation) | FLUTICASONE PROPIONATE 230 mcg/1; SALMETEROL XINAFOATE 21 mcg | Advair HFA (brand) | $30.53–$35.00 per gram | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Fluticasone and Salmeterol Oral Inhalation Brand Names
Fluticasone and Salmeterol Oral Inhalation has 4 brand names on record: Advair Diskus, Advair HFA, AirDuo RespiClick and Wixela Inhub. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Fluticasone and Salmeterol Oral Inhalation: Manufacturers and Labelers
14 companies list Fluticasone and Salmeterol Oral Inhalation products with the FDA. By number of product records, the largest are A-S Medication Solutions, GlaxoSmithKline LLC, Prasco Laboratories. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Fluticasone and Salmeterol Oral Inhalation Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. A-S Medication Solutions is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →